Moran Patricia 4
4 · Vroom, Inc. · Filed Feb 11, 2021
Insider Transaction Report
Form 4
Vroom, Inc.VRM
Moran Patricia
See remarks
Transactions
- Exercise/Conversion
Common Stock
2021-02-09$4.21/sh+29,400$123,774→ 61,144 total - Sale
Common Stock
2021-02-09$50.00/sh−29,400$1,470,123→ 31,744 total - Exercise/Conversion
Common Stock
2021-02-10$4.21/sh+45,600$191,976→ 77,344 total - Sale
Common Stock
2021-02-10$50.09/sh−45,600$2,283,908→ 31,744 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-09−29,400→ 270,600 totalExercise: $4.21Exp: 2029-02-06→ Common Stock (29,400 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-10−45,600→ 225,000 totalExercise: $4.21Exp: 2029-02-06→ Common Stock (45,600 underlying)
Footnotes (5)
- [F1]The securities reported herein, as well as the exercise price of the stock option, have been adjusted to reflect a 2-for-1 forward stock split of the Issuer's common stock that occurred on June 11, 2020.
- [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2020.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.33. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The option is vested and exercisable as to 150,000 shares, and the remaining shares vest and become exercisable in two equal annual installments beginning on January 14, 2022.